Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration.
Wilde DC, Castro PD, Bera K, Lai S, Madabhushi A, Corredor G, Koyuncu C, Lewis JS Jr, Lu C, Frederick MJ, Frederick AM, Haugen AE, Zevallos JP, Sturgis EM, Shi J, Huang AT, Hernandez DJ, Skinner HD, Kemnade JO, Yu W, Sikora AG, Sandulache VC. Wilde DC, et al. Among authors: bera k. Mod Pathol. 2022 Aug;35(8):1045-1054. doi: 10.1038/s41379-022-01024-8. Epub 2022 Feb 18. Mod Pathol. 2022. PMID: 35184149 Free PMC article.
Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features.
Khorrami M, Jain P, Bera K, Alilou M, Thawani R, Patil P, Ahmad U, Murthy S, Stephans K, Fu P, Velcheti V, Madabhushi A. Khorrami M, et al. Among authors: bera k. Lung Cancer. 2019 Sep;135:1-9. doi: 10.1016/j.lungcan.2019.06.020. Epub 2019 Jul 5. Lung Cancer. 2019. PMID: 31446979 Free PMC article.
Corrigendum to "Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features" [Lung Cancer 135 (September) (2019) 1-9].
Khorrami M, Jain P, Bera K, Alilou M, Thawani R, Patil P, Ahmad U, Murthy S, Stephans K, Fu P, Velcheti V, Madabhushi A. Khorrami M, et al. Among authors: bera k. Lung Cancer. 2019 Oct;136:156. doi: 10.1016/j.lungcan.2019.08.012. Epub 2019 Aug 21. Lung Cancer. 2019. PMID: 31564290 No abstract available.
Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer.
Khorrami M, Prasanna P, Gupta A, Patil P, Velu PD, Thawani R, Corredor G, Alilou M, Bera K, Fu P, Feldman M, Velcheti V, Madabhushi A. Khorrami M, et al. Among authors: bera k. Cancer Immunol Res. 2020 Jan;8(1):108-119. doi: 10.1158/2326-6066.CIR-19-0476. Epub 2019 Nov 12. Cancer Immunol Res. 2020. PMID: 31719058 Free PMC article.
Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma.
Beig N, Bera K, Prasanna P, Antunes J, Correa R, Singh S, Saeed Bamashmos A, Ismail M, Braman N, Verma R, Hill VB, Statsevych V, Ahluwalia MS, Varadan V, Madabhushi A, Tiwari P. Beig N, et al. Among authors: bera k. Clin Cancer Res. 2020 Apr 15;26(8):1866-1876. doi: 10.1158/1078-0432.CCR-19-2556. Epub 2020 Feb 20. Clin Cancer Res. 2020. PMID: 32079590 Free PMC article.
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Khorrami M, Bera K, Leo P, Vaidya P, Patil P, Thawani R, Velu P, Rajiah P, Alilou M, Choi H, Feldman MD, Gilkeson RC, Linden P, Fu P, Pass H, Velcheti V, Madabhushi A. Khorrami M, et al. Among authors: bera k. Lung Cancer. 2020 Apr;142:90-97. doi: 10.1016/j.lungcan.2020.02.018. Epub 2020 Feb 26. Lung Cancer. 2020. PMID: 32120229 Free PMC article.
210 results